 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
The Journal of Neuroscience, January 24, 2007, 27(4):796-807; doi:10.1523/JNEUROSCI.3501-06.2007
Previous Article | Next Article
Neurobiology of Disease
Aß Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease
Pascale N. Lacor, Maria C. Buniel, Paul W. Furlow, Antonio Sanz Clemente, Pauline T. Velasco, Margaret Wood, Kirsten L. Viola, andWilliam L. Klein Department of Neurobiology and Physiology, Northwestern University, Evanston, Illinois 60208
Correspondence should be addressed to either William L. Klein or Pascale N. Lacor, Department of Neurobiology and Physiology, Northwestern University, O. T. Hogan Biological Sciences, Room 5-110, 2205 Tech Drive, Evanston, IL 60208. Email: wklein{at}northwestern.edu, Email: p-lacor{at}northwestern.edu
The basis for memory loss in early Alzheimer's disease (AD) seems likely to involve synaptic damage caused by soluble Aß-derived oligomers (ADDLs). ADDLs have been shown to build up in the brain and CSF of AD patients and are known to interfere with mechanisms of synaptic plasticity, acting as gain-of-function ligands that attach to synapses. Because of the correlation between AD dementia and synaptic degeneration, we investigated here the ability of ADDLs to affect synapse composition, structure, and abundance. Using highly differentiated cultures of hippocampal neurons, a preferred model for studies of synapse cell biology, we found that ADDLs bound to neurons with specificity, attaching to presumed excitatory pyramidal neurons but not GABAergic neurons. Fractionation of ADDLs bound to forebrain synaptosomes showed association with postsynaptic density complexes containing NMDA receptors, consistent with observed attachment of ADDLs to dendritic spines. During binding to hippocampal neurons, ADDLs promoted a rapid decrease in membrane expression of memory-related receptors (NMDA and EphB2). Continued exposure resulted in abnormal spine morphology, with induction of long thin spines reminiscent of the morphology found in mental retardation, deafferentation, and prionoses. Ultimately, ADDLs caused a significant decrease in spine density. Synaptic deterioration, which was accompanied by decreased levels of the spine cytoskeletal protein drebrin, was blocked by the Alzheimer's therapeutic drug Namenda. The observed disruption of dendritic spines links ADDLs to a major facet of AD pathology, providing strong evidence that ADDLs in AD brain cause neuropil damage believed to underlie dementia.
Key words: ADDLs; dendritic spine; synaptosomes; NMDA-R; EphB2; memantine; drebrin
Received Aug. 11, 2006; revised Dec. 13, 2006; accepted Dec. 15, 2006.
Correspondence should be addressed to either William L. Klein or Pascale N. Lacor, Department of Neurobiology and Physiology, Northwestern University, O. T. Hogan Biological Sciences, Room 5-110, 2205 Tech Drive, Evanston, IL 60208. Email: wklein{at}northwestern.edu, Email: p-lacor{at}northwestern.edu
This article has been cited by other articles:
D. L. Smith, J. Pozueta, B. Gong, O. Arancio, and M. Shelanski
Reversal of long-term dendritic spine alterations in Alzheimer disease models
PNAS, September 29, 2009; 106(39): 16877 - 16882.
[Abstract] [Full Text] [PDF]
C. F. Lippa
Compensating for Alzheimer lesions: Evidence that size counts
Neurology, September 1, 2009; 73(9): 656 - 657.
[Full Text] [PDF]
A. Auffret, V. Gautheron, M. Repici, R. Kraftsik, H. T. J. Mount, J. Mariani, and C. Rovira
Age-Dependent Impairment of Spine Morphology and Synaptic Plasticity in Hippocampal CA1 Neurons of a Presenilin 1 Transgenic Mouse Model of Alzheimer's Disease
J. Neurosci., August 12, 2009; 29(32): 10144 - 10152.
[Abstract] [Full Text] [PDF]
M. Blurton-Jones, M. Kitazawa, H. Martinez-Coria, N. A. Castello, F.-J. Muller, J. F. Loring, T. R. Yamasaki, W. W. Poon, K. N. Green, and F. M. LaFerla
Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease
PNAS, August 11, 2009; 106(32): 13594 - 13599.
[Abstract] [Full Text] [PDF]
S. Peng, D. J. Garzon, M. Marchese, W. Klein, S. D. Ginsberg, B. M. Francis, H. T. J. Mount, E. J. Mufson, A. Salehi, and M. Fahnestock
Decreased Brain-Derived Neurotrophic Factor Depends on Amyloid Aggregation State in Transgenic Mouse Models of Alzheimer's Disease
J. Neurosci., July 22, 2009; 29(29): 9321 - 9329.
[Abstract] [Full Text] [PDF]
X. Wang, B. Su, H.-g. Lee, X. Li, G. Perry, M. A. Smith, and X. Zhu
Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease
J. Neurosci., July 15, 2009; 29(28): 9090 - 9103.
[Abstract] [Full Text] [PDF]
W.-Q. Zhao, P. N. Lacor, H. Chen, M. P. Lambert, M. J. Quon, G. A. Krafft, and W. L. Klein
Insulin Receptor Dysfunction Impairs Cellular Clearance of Neurotoxic Oligomeric A{beta}
J. Biol. Chem., July 10, 2009; 284(28): 18742 - 18753.
[Abstract] [Full Text] [PDF]
F.-F. Liao and H. Xu
Insulin Signaling in Sporadic Alzheimer's Disease
Sci. Signal., June 9, 2009; 2(74): pe36 - pe36.
[Abstract] [Full Text] [PDF]
G. G. Farias, I. E. Alfaro, W. Cerpa, C. P. Grabowski, J. A. Godoy, C. Bonansco, and N. C. Inestrosa
Wnt-5a/JNK Signaling Promotes the Clustering of PSD-95 in Hippocampal Neurons
J. Biol. Chem., June 5, 2009; 284(23): 15857 - 15866.
[Abstract] [Full Text] [PDF]
S. E. Hoey, R. J. Williams, and M. S. Perkinton
Synaptic NMDA Receptor Activation Stimulates {alpha}-Secretase Amyloid Precursor Protein Processing and Inhibits Amyloid-{beta} Production
J. Neurosci., April 8, 2009; 29(14): 4442 - 4460.
[Abstract] [Full Text] [PDF]
G. Pigino, G. Morfini, Y. Atagi, A. Deshpande, C. Yu, L. Jungbauer, M. LaDu, J. Busciglio, and S. Brady
Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta
PNAS, April 7, 2009; 106(14): 5907 - 5912.
[Abstract] [Full Text] [PDF]
A. Deshpande, H. Kawai, R. Metherate, C. G. Glabe, and J. Busciglio
A Role for Synaptic Zinc in Activity-Dependent A{beta} Oligomer Formation and Accumulation at Excitatory Synapses
J. Neurosci., April 1, 2009; 29(13): 4004 - 4015.
[Abstract] [Full Text] [PDF]
S. Mandrekar, Q. Jiang, C. Y. D. Lee, J. Koenigsknecht-Talboo, D. M. Holtzman, and G. E. Landreth
Microglia Mediate the Clearance of Soluble A{beta} through Fluid Phase Macropinocytosis
J. Neurosci., April 1, 2009; 29(13): 4252 - 4262.
[Abstract] [Full Text] [PDF]
R. M. Koffie, M. Meyer-Luehmann, T. Hashimoto, K. W. Adams, M. L. Mielke, M. Garcia-Alloza, K. D. Micheva, S. J. Smith, M. L. Kim, V. M. Lee, et al.
Oligomeric amyloid {beta} associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques
PNAS, March 10, 2009; 106(10): 4012 - 4017.
[Abstract] [Full Text] [PDF]
S. Knafo, L. Alonso-Nanclares, J. Gonzalez-Soriano, P. Merino-Serrais, I. Fernaud-Espinosa, I. Ferrer, and J. DeFelipe
Widespread Changes in Dendritic Spines in a Model of Alzheimer's Disease
Cereb Cortex, March 1, 2009; 19(3): 586 - 592.
[Abstract] [Full Text] [PDF]
K. Nishitsuji, T. Tomiyama, K. Ishibashi, K. Ito, R. Teraoka, M. P. Lambert, W. L. Klein, and H. Mori
The E693{Delta} Mutation in Amyloid Precursor Protein Increases Intracellular Accumulation of Amyloid {beta} Oligomers and Causes Endoplasmic Reticulum Stress-Induced Apoptosis in Cultured Cells
Am. J. Pathol., March 1, 2009; 174(3): 957 - 969.
[Abstract] [Full Text] [PDF]
F. G. De Felice, M. N. N. Vieira, T. R. Bomfim, H. Decker, P. T. Velasco, M. P. Lambert, K. L. Viola, W.-Q. Zhao, S. T. Ferreira, and W. L. Klein
From the Cover: Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of A{beta} oligomers
PNAS, February 10, 2009; 106(6): 1971 - 1976.
[Abstract] [Full Text] [PDF]
R. Adalbert, A. Nogradi, E. Babetto, L. Janeckova, S. A. Walker, M. Kerschensteiner, T. Misgeld, and M. P. Coleman
Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies
Brain, February 1, 2009; 132(2): 402 - 416.
[Abstract] [Full Text] [PDF]
N. Louneva, J. W. Cohen, L.-Y. Han, K. Talbot, R. S. Wilson, D. A. Bennett, J. Q. Trojanowski, and S. E. Arnold
Caspase-3 Is Enriched in Postsynaptic Densities and Increased in Alzheimer's Disease
Am. J. Pathol., November 1, 2008; 173(5): 1488 - 1495.
[Abstract] [Full Text] [PDF]
N. H. Varvel, K. Bhaskar, A. R. Patil, S. W. Pimplikar, K. Herrup, and B. T. Lamb
A{beta} Oligomers Induce Neuronal Cell Cycle Events in Alzheimer's Disease
J. Neurosci., October 22, 2008; 28(43): 10786 - 10793.
[Abstract] [Full Text] [PDF]
K. L. Richard, M. Filali, P. Prefontaine, and S. Rivest
Toll-Like Receptor 2 Acts as a Natural Innate Immune Receptor to Clear Amyloid {beta}1-42 and Delay the Cognitive Decline in a Mouse Model of Alzheimer's Disease
J. Neurosci., May 28, 2008; 28(22): 5784 - 5793.
[Abstract] [Full Text] [PDF]
Q.-L. Ma, F. Yang, F. Calon, O. J. Ubeda, J. E. Hansen, R. H. Weisbart, W. Beech, S. A. Frautschy, and G. M. Cole
p21-activated Kinase-aberrant Activation and Translocation in Alzheimer Disease Pathogenesis
J. Biol. Chem., May 16, 2008; 283(20): 14132 - 14143.
[Abstract] [Full Text] [PDF]
E. Sturchler, A. Galichet, M. Weibel, E. Leclerc, and C. W. Heizmann
Site-Specific Blockade of RAGE-Vd Prevents Amyloid-{beta} Oligomer Neurotoxicity
J. Neurosci., May 14, 2008; 28(20): 5149 - 5158.
[Abstract] [Full Text] [PDF]
V. Nimmrich, C. Grimm, A. Draguhn, S. Barghorn, A. Lehmann, H. Schoemaker, H. Hillen, G. Gross, U. Ebert, and C. Bruehl
Amyloid {beta} Oligomers (A{beta}1-42 Globulomer) Suppress Spontaneous Synaptic Activity by Inhibition of P/Q-Type Calcium Currents
J. Neurosci., January 23, 2008; 28(4): 788 - 797.
[Abstract] [Full Text] [PDF]
S. Petratos, Q.-X. Li, A. J. George, X. Hou, M. L. Kerr, S. E. Unabia, I. Hatzinisiriou, D. Maksel, M.-I. Aguilar, and D. H. Small
The -amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism
Brain, January 1, 2008; 131(1): 90 - 108.
[Abstract] [Full Text] [PDF]
D. V. Venkitaramani, J. Chin, W. J. Netzer, G. K. Gouras, S. Lesne, R. Malinow, and P. J. Lombroso
{beta}-Amyloid Modulation of Synaptic Transmission and Plasticity
J. Neurosci., October 31, 2007; 27(44): 11832 - 11837.
[Full Text] [PDF]
F. G. De Felice, P. T. Velasco, M. P. Lambert, K. Viola, S. J. Fernandez, S. T. Ferreira, and W. L. Klein
Abeta Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine
J. Biol. Chem., April 13, 2007; 282(15): 11590 - 11601.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|